Table 1 Characteristics of TNBC patients
From: MiR-34b is associated with clinical outcome in triple-negative breast cancer patients
| Â | Total (n = 39) | % |
|---|---|---|
Age (years) | Â | Â |
Median (range) | 44 (29 - 75) | Â |
Grade | Â | Â |
I | 0 | 0 |
II | 7 | 18 |
III | 32 | 82 |
Histology | Â | Â |
Medullary | 6 | 15 |
Invasive ductal | 33 | 85 |
BRCA1 status | Â | Â |
Wild-type | 8 | 21 |
Mutated | 13 | 33 |
NA | 18 | 46 |
T | Â | Â |
1 | 10 | 26 |
2 | 21 | 54 |
3 | 4 | 10 |
4 | 4 | 10 |
N | Â | Â |
0 | 17 | 44 |
1 | 13 | 33 |
2 | 7 | 18 |
3 | 2 | 5 |
Clinical stage | Â | Â |
I | 7 | 18 |
II | 21 | 54 |
III | 11 | 28 |
IV | 0 | 0 |